What is American Strategic Investment Co.'s earnings per share (EPS)?

American Strategic Investment Co. (NYC) reported diluted earnings per share of $-8.32 for fiscal year 2025. This represents a 85.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

American Strategic Investment Co. Financials

NYC

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows American Strategic Investment Co. (NYC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 12 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI NYC FY2025 2026-05-15

American Strategic Investment is being shaped less by revenue growth than by a smaller asset base, interest drag, and cash strain.

From FY2023 to FY2025, total assets fell from $694.2M to $445.2M, showing a business getting materially smaller on paper. Liabilities also declined, but equity thinned faster than obligations, so debt-to-equity still worsened from 2.1x to 5.9x and each remaining dollar of equity now supports more balance-sheet risk.

FY2025 shows a reported operating recovery, but not a fully economic one: operating income turned positive at $4.4M while interest expense of $15.3M still pulled results below net-income break-even. Cash conversion remained weak because operating cash flow was -$7.8M even with EBITDA of $17.2M, so the turnaround has not yet become self-funding.

The company is asset-heavy but cash-light: FY2025 ended with only $1.3M of cash against $380.4M of total liabilities. That mismatch means the balance sheet may still hold substantial assets, yet near-term flexibility depends less on book value than on whether operations can stop consuming cash.

Financial Health Signals

Financial Profile 0/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of American Strategic Investment Co.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Leverage

American Strategic Investment Co. has elevated debt relative to equity (D/E of 5.87), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.

Returns

American Strategic Investment Co. generates a -32.7% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is up from -164.3% the prior year.

Piotroski F-Score Weak

2/9

American Strategic Investment Co. passes 2 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).

Earnings Quality Low Quality

0.37x

For every $1 of reported earnings, American Strategic Investment Co. generates $0.37 in operating cash flow (-$7.8M OCF vs -$21.2M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

0.3x

American Strategic Investment Co. earns $0.3 in operating income for every $1 of interest expense ($4.4M vs $15.3M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

$17.2M

YoY+116.7%

5Y CAGR+13.5%

10Y CAGR+14.8%

American Strategic Investment Co.'s EBITDA was $17.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 116.7% from the prior year.

Net Income

-$21.2M

YoY+84.9%

American Strategic Investment Co. reported -$21.2M in net income in fiscal year 2025. This represents an increase of 84.9% from the prior year.

EPS (Diluted)

$-8.32

YoY+85.3%

American Strategic Investment Co. earned $-8.32 per diluted share (EPS) in fiscal year 2025. This represents an increase of 85.3% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$1.3M

YoY-86.7%

5Y CAGR-47.0%

10Y CAGR-39.0%

American Strategic Investment Co. held $1.3M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

YoY+1.5%

American Strategic Investment Co. had 3M shares outstanding in fiscal year 2025. This represents an increase of 1.5% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

-32.7%

YoY+131.5pp

5Y CAGR-21.9pp

10Y CAGR-30.1pp

American Strategic Investment Co.'s ROE was -32.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 131.5 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

YoY-100.0%

American Strategic Investment Co. spent $0 on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 100.0% from the prior year.

Capital Expenditures

N/A

NYC Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	N/A	$0-100.0%	$700K-12.5%	$800K	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$8.3M-10.3%	$9.2M-1.7%	$9.4M-25.0%	$12.5M+43.5%	$8.7M+15.0%	$7.6M
Operating Income	$4.4M+103.6%	-$121.2M-39.2%	-$87.1M-223.3%	-$26.9M-32.2%	-$20.4M+9.8%	-$22.6M
Interest Expense	$15.3M-21.6%	$19.5M+3.3%	$18.9M-0.3%	$18.9M-0.9%	$19.1M-0.3%	$19.1M
Income Tax	$0	$0	$0	$0-100.0%	$37K	$0
Net Income	-$21.2M+84.9%	-$140.6M-32.7%	-$105.9M-130.8%	-$45.9M-16.3%	-$39.5M+3.7%	-$41.0M
EPS (Diluted)	$-8.32+85.3%	$-56.51-18.8%	$-47.57-78.9%	$-26.59-8.9%	$-24.42	$-25.67

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$2.3M	N/A	$1.8M-19.2%	$2.2M-30.7%	$3.1M	N/A	$1.8M-10.3%	$2.0M
Operating Income	-$1.5M	N/A	$43.0M+227.3%	-$33.8M-648.9%	-$4.5M	N/A	-$29.2M+66.3%	-$86.7M
Interest Expense	$4.0M	N/A	$4.1M-47.5%	$7.8M+92.3%	$4.1M	N/A	$5.3M+1.5%	$5.2M
Income Tax	$0	N/A	N/A	N/A	$0	N/A	N/A	N/A
Net Income	-$7.8M	N/A	$35.8M+185.8%	-$41.7M-384.9%	-$8.6M	N/A	-$34.5M+62.5%	-$91.9M
EPS (Diluted)	$-3.04	N/A	$13.60+183.0%	$-16.39-383.5%	$-3.39	N/A	$-13.52+62.9%	$-36.48

NYC Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$445.2M-12.2%	$507.1M-27.0%	$694.2M-12.2%	$790.5M-4.0%	$823.1M-4.5%	$861.8M
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$1.3M-86.7%	$9.8M+84.7%	$5.3M-42.6%	$9.2M-21.1%	$11.7M-62.3%	$31.0M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$380.4M-9.7%	$421.5M-10.2%	$469.4M+0.1%	$468.9M-0.6%	$471.9M-1.7%	$480.3M
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$64.8M-24.3%	$85.6M-61.9%	$224.8M-25.3%	$301.1M-11.2%	$339.0M-10.2%	$377.6M
Retained Earnings	-$667.1M-3.3%	-$645.9M-27.8%	-$505.3M-26.5%	-$399.4M-13.9%	-$350.7M-14.7%	-$305.9M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$445.0M0.0%	$445.2M-0.6%	$448.1M-3.4%	$464.0M-7.1%	$499.4M-1.5%	$507.1M-10.7%	$567.9M-5.2%	$598.9M
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$2.5M+92.8%	$1.3M-61.3%	$3.4M-36.9%	$5.3M-25.0%	$7.1M-27.5%	$9.8M+86.8%	$5.2M+0.2%	$5.2M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$387.9M+2.0%	$380.4M+1.0%	$376.7M-12.1%	$428.5M+1.5%	$422.3M+0.2%	$421.5M-11.4%	$475.5M+0.7%	$472.1M
Current Liabilities	N/A	N/A	N/A	$99.0M	N/A	N/A	N/A	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$57.1M-11.9%	$64.8M-9.3%	$71.4M+100.9%	$35.5M-53.9%	$77.1M-9.9%	$85.6M-7.3%	$92.4M-27.1%	$126.8M
Retained Earnings	-$674.8M-1.2%	-$667.1M-1.0%	-$660.4M+5.1%	-$696.1M-6.4%	-$654.5M-1.3%	-$645.9M-1.0%	-$639.2M-5.7%	-$604.7M

NYC Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$7.8M-93.9%	-$4.0M+46.0%	-$7.4M-1423.7%	-$486K+93.9%	-$7.9M+41.7%	-$13.6M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$3.8M-106.3%	$59.9M+84205.6%	$71K+101.3%	-$5.6M-64.6%	-$3.4M+10.1%	-$3.8M
Financing Cash Flow	$650K+101.3%	-$49.7M-1335.6%	$4.0M+164.2%	-$6.3M-2180.0%	-$275K+71.6%	-$970K
Dividends Paid	N/A	$0	$0-100.0%	$2.7M-48.7%	$5.2M+736.2%	$622K
Share Buybacks	$0-100.0%	$231K	$0	$0-100.0%	$183K	$0

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	-$182K+93.9%	-$3.0M-484.9%	$777K+131.1%	-$2.5M+17.6%	-$3.0M+58.4%	-$7.3M-384.7%	$2.6M+380.0%	-$916K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$101K-197.1%	-$34K+98.9%	-$3.2M-557.0%	-$486K-575.0%	-$72K-100.1%	$60.8M+17125.8%	-$357K-75.0%	-$204K
Financing Cash Flow	$400K-38.5%	$650K	$0	$0	$0+100.0%	-$50.3M-11936.7%	$425K+183.3%	$150K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

NYC Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	-12443.1%-9075.0pp	-3368.1%	N/A	N/A
Net Margin	N/A	N/A	-15132.0%-9395.0pp	-5737.0%	N/A	N/A
Return on Equity	-32.7%+131.5pp	-164.3%-117.2pp	-47.1%-31.9pp	-15.2%-3.6pp	-11.6%-0.8pp	-10.8%
Return on Assets	-4.8%+23.0pp	-27.7%-12.5pp	-15.3%-9.5pp	-5.8%-1.0pp	-4.8%-0.1pp	-4.8%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	5.87+0.9	4.92+2.8	2.09+0.5	1.56+0.2	1.39+0.1	1.27
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	-13.6%	N/A	50.1%+167.4pp	-117.3%-106.1pp	-11.2%	N/A	-37.3%+35.1pp	-72.5%
Return on Assets	-1.8%	N/A	8.0%+17.0pp	-9.0%-7.3pp	-1.7%	N/A	-6.1%+9.3pp	-15.3%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	6.80+0.9	5.87+0.6	5.28-6.8	12.06+6.6	5.48+0.6	4.92-0.2	5.15+1.4	3.72
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

CHG

$34.5M

Ohmyhome Limited OMH

$19.9M

Fangdd Network Group Ltd. DUO

$46.3M

Rafael Holdings RFL

$69.2M

Gyrodyne Llc GYRO

$16.8M

Frequently Asked Questions

Is American Strategic Investment Co. profitable?

No, American Strategic Investment Co. (NYC) reported a net income of -$21.2M in fiscal year 2025.

What is American Strategic Investment Co.'s EBITDA?

American Strategic Investment Co. (NYC) had EBITDA of $17.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is American Strategic Investment Co.'s return on equity (ROE)?

American Strategic Investment Co. (NYC) has a return on equity of -32.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is American Strategic Investment Co.'s operating cash flow?

American Strategic Investment Co. (NYC) generated -$7.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are American Strategic Investment Co.'s total assets?

American Strategic Investment Co. (NYC) had $445.2M in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does American Strategic Investment Co. have outstanding?

American Strategic Investment Co. (NYC) had 3M shares outstanding as of fiscal year 2025.

What is American Strategic Investment Co.'s debt-to-equity ratio?

American Strategic Investment Co. (NYC) had a debt-to-equity ratio of 5.87 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is American Strategic Investment Co.'s return on assets (ROA)?

American Strategic Investment Co. (NYC) had a return on assets of -4.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is American Strategic Investment Co.'s cash runway?

Based on fiscal year 2025 data, American Strategic Investment Co. (NYC) had $1.3M in cash against an annual operating cash burn of $7.8M. This gives an estimated cash runway of approximately 2 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is American Strategic Investment Co.'s Piotroski F-Score?

American Strategic Investment Co. (NYC) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are American Strategic Investment Co.'s earnings high quality?

American Strategic Investment Co. (NYC) has an earnings quality ratio of 0.37x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can American Strategic Investment Co. cover its interest payments?

American Strategic Investment Co. (NYC) has an interest coverage ratio of 0.3x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is American Strategic Investment Co.?

American Strategic Investment Co. (NYC) scores 0 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.